Ligand validation:6MYM

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6MYM designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6MYM_NAG_B_701	59%	77%	0.163	0.945	0.34	0.56	-	-	0	0	100%	0.9333
6MYM_NAG_C_601	33%	72%	0.187	0.867	0.43	0.65	-	1	0	0	100%	0.9333
6MYM_NAG_C_610	15%	27%	0.264	0.823	0.65	2.24	-	5	0	0	100%	0.9333
6MYM_NAG_B_702	14%	49%	0.228	0.774	0.66	1.31	1	2	0	0	100%	0.9333
6MYM_NAG_A_611	11%	86%	0.274	0.798	0.18	0.54	-	-	1	0	100%	0.9333
6MYM_NAG_B_709	5%	87%	0.288	0.682	0.26	0.43	-	-	1	0	100%	0.9333
6MYM_NAG_B_708	4%	45%	0.317	0.701	0.73	1.39	-	3	0	0	100%	0.9333
6MYM_NAG_C_604	4%	76%	0.371	0.751	0.5	0.45	-	-	0	0	100%	0.9333
6N08_NAG_A_703	65%	57%	0.136	0.937	0.62	1.02	-	1	0	0	100%	0.9333
6MXU_NAG_B_601	58%	51%	0.159	0.937	0.75	1.15	1	1	0	0	100%	0.9333
6P6P_NAG_F_701	34%	49%	0.176	0.858	0.76	1.21	1	1	0	0	100%	0.9333
6XPO_NAG_B_601	27%	77%	0.237	0.885	0.35	0.57	-	-	1	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.